CIK 0001762303 · Non-accelerated filer<br>Smaller reporting company
AVITA Medical, Inc.
Sign in to watch- Tickers
- RCEL AVHHL
- Exchange
- Nasdaq, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202578762
- Phone
- 661-568-1317
- Business address
- 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
- Former names
- Avita Therapeutics, Inc., Avita Medical, Ltd.
Securities
- RCEL Common Stock Nasdaq
- AVHHL Common stock OTC
- 4 Grant or award Chief Legal Officer acquired 98,390 shares (grant or award)
- 4 Open-market buy Director bought 10,000 shares at $4.50 ($45,000)
- 4 Open-market buy CFO bought 2,000 shares at $4.52 ($9,040)
- 4 Open-market buy Director bought 10,000 shares at $5.00 ($50,000)
- 4 Open-market buy CFO bought 2,000 shares at $4.81 ($9,620)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 10,022 shares (grant or award)
- 4 Grant or award Director acquired 10,022 shares (grant or award)
- 4 Grant or award Director acquired 10,022 shares (grant or award)
- 4 Grant or award Director acquired 10,022 shares (grant or award)
- 4 Grant or award Director acquired 10,022 shares (grant or award)
- 4 Grant or award Director acquired 10,022 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CFO acquired 1,923 shares (grant or award)
- 4 Open-market buy Director bought 11,000 shares at $8.30 ($91,300)
- 4 Open-market buy Director bought 10,000 shares at $10.09 ($100,900)
- 4 Open-market buy CFO bought 1,000 shares at $9.90 ($9,900)
- 4 Open-market buy CFO bought 1,000 shares at $10.25 ($10,250)
- 4 Open-market buy Director bought 486 shares at $13.15 ($6,391)
- 4 Derivatives Options or other derivatives
Page 2 of 7 · 140 filings